Perrigo Co PLC (PRGO)
43.29
-0.13 -0.30%
NYSE
Jan 22, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 5.097B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.06 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -6.60M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 35.27% |
| Profit Margin (Quarterly) | -12.74% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 2.08% |
| Price and Valuation | |
| Market Cap | 5.909B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 1.164 |
| PE Ratio | -- |
| Price to Book Value | 1.015 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.6117 |
| Free Cash Flow (Quarterly) | 18.90M |
| Return on Equity | Upgrade |
View All PRGO News
News
-
WireHeadlineTime (ET)
-
Yahoo01/19 13:29
-
PR Newswire01/11 08:00
-
Yahoo01/11 06:50
-
Yahoo01/10 10:43
-
MT Newswires01/06 08:40
-
PR Newswire12/17 08:03
-
Yahoo12/10 09:40
-
Yahoo12/07 10:56
-
Yahoo12/06 08:10
-
Yahoo12/04 11:31
-
PR Newswire11/17 08:15
-
Globe Newswire11/12 07:05
-
Yahoo11/12 07:05
-
Yahoo11/12 07:02
-
Yahoo11/09 13:02
-
Yahoo11/05 15:48
-
SA Breaking News11/05 11:59
-
Yahoo11/05 09:37
-
Yahoo11/05 06:14
-
MT Newswires11/05 02:45
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/26/2021 | Earnings | Perrigo Co PLC Fourth Quarter Earnings for 2020 Release |
| 02/26/2021 08:30 EST | Misc | Perrigo Co PLC Fourth Quarter Earnings Conference Call for 2020 |
| 11/25/2020 | Dividends | Amount: 0.225, Declared Date: Oct 22 2020, Pay Date: Dec 15 2020 |
| 11/04/2020 | Earnings | Perrigo Co PLC Third Quarter Earnings Result for 2020 |
| 11/04/2020 16:30 EST | Misc | Perrigo Co PLC Third Quarter Earnings Conference Call for 2020 |
| 08/27/2020 | Dividends | Amount: 0.225, Declared Date: Jul 29 2020, Pay Date: Sep 15 2020 |
| 08/05/2020 09:00 EDT | Misc | Perrigo Co PLC Second Quarter Earnings Conference Call for 2020 |
| 08/05/2020 | Earnings | Perrigo Co PLC Second Quarter Earnings Result for 2020 |
| 05/28/2020 | Dividends | Amount: 0.225, Declared Date: May 05 2020, Pay Date: Jun 16 2020 |
| 05/06/2020 11:30 IST | Misc | Perrigo Co PLC Annual General Meeting for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.perrigo.com
- Investor Relations URL: http://perrigo.investorroom.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Small Cap/Value
- Next Earnings Release: Feb. 26, 2021
- Last Earnings Release: Nov. 04, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Nov. 25, 2020
- Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to OTC and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 43.29 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| XPH | SPDR® S&P Pharmaceuticals ETF | 3.72% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.37% |
| SSHVX | Sound Shore Institutional | 3.23% |
| CSINX | Centerstone International C | 2.82% |
| TMCTX | Touchstone Mid Cap Z | 2.37% |
| PILL | Direxion Daily Phrmctcl&MdclBl3XShrsETF | 2.24% |
| IHE | iShares US Pharmaceuticals ETF | 2.10% |
| CENNX | Centerstone Investors C | 2.07% |
| PPH | VanEck Vectors Pharmaceutical ETF | 2.05% |
| GRX | Gabelli Health & Wellness | 1.60% |
| FPHAX | Fidelity® Select Pharmaceuticals Port | 1.31% |
| DTMVX | DFA Tax-Managed US Targeted Value | 0.43% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRGO Tweets Stocktwits
Advertisement
